Management of Patients Symptomatically Unresponsive to Levothyroxine: Natural Desiccated Thyroid Extract or the Combination of Levothyroxine and Liothyronine? A Research Priority

Abstract

Around 5–10% of hypothyroid patients continue to experience profound and sometimes disabling symptoms, including fatigue, depression and impaired cognition, in spite of being adequately replaced biochemically. The use of the combination of levothyroxine and liothyronine and natural desiccated thyroid extract is controversial for reasons of costs, a lack of evidence of additional benefit over levothyroxine alone, and potential safety concerns. Clinical guidelines caution against the use of both, and advise that only in exceptional cases may a short trial be considered. Natural desiccated thyroid extract is not licensed for use in the UK. However, key deficiencies in the existing evidence-base together with improved understanding of the pharmacology of levothyroxine resistance, indicates that now is the right time for a definitive clinical trial to address this important area of uncertainty.

Keywords

Primary hypothyroidism - levothyroxine-liothyronine therapy - resistant - T3 - liothyronine - natural desiccated thyroid extract

Publication History

Article published online:
09 December 2019

• References

• 1 Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F. et al. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab 2014; 99: 923-931
• 2 Saravanan P, Chau WF, Roberts N. et al. well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol 2002; 57: 577-585
• 3 NHS England 2017. Items which should not routinely be prescribed in primary care: Guidance for CCGs https://www.england.nhs.uk/wp-content/uploads/2017/11/items-which-should-not-be-routinely-precscribed-in-pc-ccg-guidance.pdf
• 4 All Wales Medicines Strategy Group 2017. Medicines Identified as Low Priority for Funding in NHS Wales. 2017; http://www.awmsg.org/docs/awmsg/medman/Medicines%20Identified%20as%20Low%20Priority%20for%20Funding%20in%20NHS%20Wales.pdf
• 5 Regional Medicines Optimisation Committee. Guidance - Prescribing of Liothyronine. 2018; https://www.sps.nhs.uk/articles/rmoc-guidance-prescribing-of-liothyronine/
• 6 Wiersinga WM, Duntas L, Fadeyev V. et al. 2012 ETA Guidelines: The Use of L-T4+L-T3 in the Treatment of Hypothyroidism. Eur Thyroid J 2012; 1: 55-71
• 7 Bunevicius R, Kazanavicius G, Zalinkevicius R. et al. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999; 340: 424-429
• 8 Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M. et al. Thyroid hormone replacement therapy in primary hypothyroidism: A randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med 2005; 142: 412-424
• 9 Nygaard B, Jensen EW, Kvetny J. et al. Effect of combination therapy with thyroxine (LEVOTHYROXINE) and 3,5,3’-triiodothyronine versus LEVOTHYROXINE monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study. Eur J Endocrinol 2009; 161: 895-902
• 10 Siegmund W, Spieker K, Weike AI. et al. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14: 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf) 2004; 60: 750-757
• 11 Bunevicius R, Jakubonien N, Jurkevicius R. et al. Thyroxine vs. thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves’ disease. Endocrine. 2002; 18: 129-133
• 12 Walsh JP, Shiels L, Lim EM. et al. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 2003; 88: 4543-4550
• 13 Rodriguez T, Lavis VR, Meininger JC. et al. Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone. Endocr Pract 2005; 11: 223-233
• 14 Appelhof BC, Fliers E, Wekking EM. et al. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 2005; 90: 2666-2674
• 15 Valizadeh M, Seyyed-Majidi MR, Hajibeigloo H. et al. Efficacy of combined levothyroxine and liothyronine as compared with levothyroxine monotherapy in primary hypothyroidism: A randomized controlled trial. Endocr Res 2009; 34: 80-89
• 16 Sawka AM, Gerstein HC, Marriott MJ. et al. Does a combination regimen of thyroxine (LEVOTHYROXINE) and 3,5,3’-triiodothyronine improve depressive symptoms better than LEVOTHYROXINE alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003; 88: 4551-4555
• 17 Fadeyev VV, Morgunova TB, Melnichenko GA. et al. Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism. Hormones (Athens) 2010; 9: 245-252
• 18 Saravanan P, Simmons DJ, Greenwood R. et al. Partial substitution of thyroxine (LEVOTHYROXINE) with tri-iodothyronine in patients on LEVOTHYROXINE replacement therapy: Results of a large community-based randomized controlled trial. J Clin Endocrinol Metab 2005; 90: 805-812
• 19 Clyde PW, Harari AE, Getka EJ. et al. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: A randomized controlled trial. JAMA 2003; 290: 2952-2958
• 20 Leese GP, Soto-Pedre E, Donnelly LA. Liothyronine use in a 17 year observational population-based study - the tears study. Clin Endocrinol (Oxf) 2016; 85: 918-925
• 21 Sawin CT, Hershman JM, Fernandez-Garcia R. et al. A comparison of thyroxine and desiccated thyroid in patients with primary hypothyrodism. Metabolism 1978; 27: 1518-1525
• 22 Singh SP, Feldman EB, Carter AC. Desiccated thryoid and levothyroxine in hypothyroidism. NY State J Med 1972; May 1045-1048
• 23 Sturnick MI, Lesses MF. A comparison of the effect of desiccated thyroid and sodium levothyroxine on the serum protein-bound iodine. N Engl J Med 1961; 264: 608-609
• 24 McGavack TH, Reckendorf HK. Therapeutic activity of desiccated thyroid substance, sodium L-thyroxine and D,L-triiodothyronine. A comparative study. Am J Med 1956; May 774-777
• 25 Hoang TD, Olsen CH, Mai VQ. et al. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: A randomized, double-blind, crossover study. J Clin Endocrinol Metab 2013; 98: 1982-1990
• 26 Castagna MG, Dentice M, Cantara S. et al. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients. J Clin Endocrinol Metab 2017; 102: 1623-1630
• 27 Bianco AC, Kim BS. Pathophysiological relevance of deiodinase polymorphism. Curr Opin Endocrinol Diabetes Obes 2018; 25: 341-346